Research

Daniel ODay

Biotech

CEO O’Day tells Fierce how Gilead reached ‘critical mass’

After a run of dealmaking, Gilead CEO Daniel O'Day told Fierce that any future M&A activity will only be done to complement the existing strategy.

Darren Incorvaia Sep 16, 2026 8:00am

Mayo Clinic teams with Thermo Fisher to form data group Precure

Sep 15, 2026 11:46am

Graphic portrayal of a cancer vaccine releasing therapeutic material that latches onto tumors

Have Moderna, Merck kicked off a 'personalized med revolution'?

Sep 11, 2026 9:00am

ADA 2026 conference

Scientists begin boycott of American Diabetes Association

Sep 11, 2026 6:30am

mushrooms psychedelic drugs psychedelics

Psilocybin proves promising in neuropathic pain mouse study

Sep 3, 2026 2:00pm

University of Toronto downtown sign

With mRNA back in the spotlight, tRNA shows potential

Aug 27, 2026 2:00pm